Literature DB >> 26677121

Headache-related disability among medical students in Amazon: a cross-sectional study.

Carlos Mauricio Oliveira de Almeida1, Paulo Antônio Machado da Silva Lima2, Rebecca Stabenow2, Rhea Sylvia de Souza Mota2, Antônio Luiz Boechat2, Massanobu Takatani2.   

Abstract

OBJECTIVE: To evaluate the prevalence of headache in medical students, and quantify the degree of disability through HIT-6 and MIDAS SCALE.
METHOD: The criteria established by International Headache Society were used and the HIT-6 and MIDAS, to asses disability.
RESULTS: 140 medical students from UFAM were evaluated. 16.43% cases of migraine headache, 6.43% of probable migraine, and 23.57% of tension headaches were detected. 6.42% reported an absence of headache; and another 11.42% had secondary headache. According to the HIT-6 questionnaire, in 7.14% and 18.57% of the students, headaches were classified as having substantial to severe impact, respectively.
CONCLUSION: Migraine and probable migraine had higher scores than the other types of headache and, therefore, led to higher levels of disability. The present study did not find a significant correlation between student semester, age or extracurricular activities on the impact generated by headache.

Entities:  

Mesh:

Year:  2015        PMID: 26677121     DOI: 10.1590/0004-282X20150172

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Epidemiological and clinical characteristics of headache among medical students in Palestine: a cross sectional study.

Authors:  Firas Anaya; Wala'a Abu Alia; Feda'a Hamoudeh; Zaher Nazzal; Beesan Maraqa
Journal:  BMC Neurol       Date:  2022-01-03       Impact factor: 2.474

2.  Management of headache and associated factors among undergraduate medicine and health science students of University of Gondar, North West Ethiopia.

Authors:  Eshetie Melese Birru; Zenahebezu Abay; Mohammedbrhan Abdelwuhab; Abebe Basazn; Betelhem Sirak; Fitsum Sebsibe Teni
Journal:  J Headache Pain       Date:  2016-05-23       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.